Literature DB >> 25666341

Initial experiences with laparoscopy and flexible ureteroscopy combination pyeloplasty in management of ectopic pelvic kidney with stone and ureter-pelvic junction obstruction.

Zhuo Yin1, Y B Wei, B L Liang, K Q Zhou, Y L Gao, B Yan, Z Wang, J R Yang.   

Abstract

To demonstrate the safety and efficacy of combine laparoscopy and flexible ureteroscopy to treat ectopic pelvic kidneys with ureteropelvic junction obstruction (UPJO) and stones. 16 patients of ectopic pelvic kidneys with ureteropelvic junction obstruction and stones were treated with laparoscopy and flexible ureteroscopy (FURS). The operative time, required dose of tramadol, visual analog pain scale (VAPS), postoperative day, stone-free rates (SFRs), perioperative complications, and serum creatinine were evaluated. The SFRs were evaluated with noncontrasted renal computed tomography (CT). Intravenous pyelography (IVP) and CT scan were used to evaluate the UPJO. Stone-free status was defined as absence of stone fragments in kidney or the size of that is less than 3 mm. Operation time from 118 to 225 min, average time (171 ± 28) min; lithotomy time from 16 to 45 min, average time (32 ± 6) min. Average tramadol required at the first day postoperation was (118 ± 49.6) mg; at the second day was (78 ± 24.8) mg. VAPS score at 24 h (5.0 ± 0.7), VAPS score at 48 h (2.5 ± 0.8). Postoperative day (3.9 ± 0.6) days. Stone-free rate was 100%. Average serum creatinine was (88.7 ± 24.3) mol/L before surgery and (92.8 ± 21.6) mol/L after surgery. No major complication. No stone and obstruction recurrence in the follow-up of average 29.3 months. Combined FUR and LC is a good option for patient of ectopic pelvic kidney with renal stone and UPJO. From our initial experience, the SFRs and the effect of pyeloplasty are satisfactory and without major complication, the operative time is acceptable.

Entities:  

Mesh:

Year:  2015        PMID: 25666341     DOI: 10.1007/s00240-015-0753-9

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  23 in total

Review 1.  Direct pelvic access percutaneous nephrolithotomy in management of ectopic kidney stone: a case report and literature review.

Authors:  Rifaioglu Murat Mehmet; Yalcinkaya Fatih Rustu; Bayarogullari Hanefi; Davarci Mursel; Aydogan Fusun; Inci Mehmet
Journal:  Ren Fail       Date:  2013-09-02       Impact factor: 2.606

Review 2.  The contemporary management of renal and ureteric calculi.

Authors:  David J Galvin; Margaret S Pearle
Journal:  BJU Int       Date:  2006-12       Impact factor: 5.588

Review 3.  Pelvic kidney: associated diseases and treatment.

Authors:  Nadya M Cinman; Zeph Okeke; Arthur D Smith
Journal:  J Endourol       Date:  2007-08       Impact factor: 2.942

4.  Laparoscopic pyelolithotomy in selected patients with ectopic pelvic kidney: a feasible minimally invasive treatment option.

Authors:  Abdelhamid M Elbahnasy; Mohamed A Elbendary; Mohamed A Radwan; Osama M Elashry; Mohamed R Taha
Journal:  J Endourol       Date:  2011-05-13       Impact factor: 2.942

5.  Complete daVinci versus laparoscopic pyeloplasty: cost analysis.

Authors:  Sam B Bhayani; Richard E Link; John M Varkarakis; Louis R Kavoussi
Journal:  J Endourol       Date:  2005-04       Impact factor: 2.942

6.  Extracorporeal shockwave lithotripsy in anomalous kidneys.

Authors:  B Küpeli; K Isen; H Biri; Z Sinik; T Alkibay; U Karaoğlan; I Bozkirli
Journal:  J Endourol       Date:  1999-06       Impact factor: 2.942

7.  Concomitant management of renal calculi and pelvi-ureteric junction obstruction with robotic laparoscopic surgery.

Authors:  Fatih Atug; Erik P Castle; Scott V Burgess; Raju Thomas
Journal:  BJU Int       Date:  2005-12       Impact factor: 5.588

8.  A clinical nomogram to predict the successful shock wave lithotripsy of renal and ureteral calculi.

Authors:  Joshua D Wiesenthal; Daniela Ghiculete; A Andrew Ray; R John D'A Honey; Kenneth T Pace
Journal:  J Urol       Date:  2011-08       Impact factor: 7.450

9.  Robotic dismembered pyeloplasty: a 6-year, multi-institutional experience.

Authors:  Patrick W Mufarrij; Michael Woods; Ojas D Shah; Michael A Palese; Aaron D Berger; Raju Thomas; Michael D Stifelman
Journal:  J Urol       Date:  2008-08-15       Impact factor: 7.450

10.  Simultaneous laparoscopic management of ureteropelvic junction obstruction and renal lithiasis: the combined experience of two academic centers and review of the literature.

Authors:  Konstantinos G Stravodimos; Stilianos Giannakopoulos; Stavros I Tyritzis; Aristeides Alevizopoulos; Stefanos Papadoukakis; Stavros Touloupidis; Constantinos A Constantinides
Journal:  Res Rep Urol       Date:  2014-05-20
View more
  5 in total

1.  The safety and efficacy of mini-percutaneous nephrolithotomy vs. retrograde intrarenal surgery for treatment of renal lithiasis in pelvic ectopic kidney: an exploratory pilot study.

Authors:  Junfeng Wu; Jun Shen
Journal:  Transl Androl Urol       Date:  2021-04

2.  Role of laparoscopy in ureteropelvic junction obstruction with concomitant pathology: a case series study.

Authors:  Omar Fahmy; Abdel-Rahman El-Fayoumi; Georgios Gakis; Bastian Amend; Mohd Ghani Khairul-Asri; Arnulf Stenzl; Christian Schwentner
Journal:  Cent European J Urol       Date:  2015-12-21

3.  Multi-tract percutaneous nephrolithotomy combined with EMS lithotripsy for bilateral complex renal stones: our experience.

Authors:  Taisheng Liang; Chenming Zhao; Gang Wu; Botao Tang; Xiangdong Luo; Shangguang Lu; Yu Dong; Huan Yang
Journal:  BMC Urol       Date:  2017-02-28       Impact factor: 2.264

4.  Retroperitoneoscopic pyeloplasty with simultaneous pyelolithotomy using a flexible cystoscope: Our initial experience at a single centre.

Authors:  Fei Zhang; Li Wang; ZheBin Gao; HouMeng Yang
Journal:  Front Surg       Date:  2022-08-19

Review 5.  Minimally invasive treatment of an ectopic kidney stone: a case report and literature review.

Authors:  Chenglu Wang; Lu Jin; Xinyang Zhao; Guobin Li; Boxin Xue
Journal:  J Int Med Res       Date:  2019-08-05       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.